Makoto Sunagawa

1.3k total citations
70 papers, 952 citations indexed

About

Makoto Sunagawa is a scholar working on Organic Chemistry, Pharmacology and Molecular Medicine. According to data from OpenAlex, Makoto Sunagawa has authored 70 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Organic Chemistry, 33 papers in Pharmacology and 27 papers in Molecular Medicine. Recurrent topics in Makoto Sunagawa's work include Antibiotics Pharmacokinetics and Efficacy (31 papers), Antibiotic Resistance in Bacteria (27 papers) and Synthesis of β-Lactam Compounds (20 papers). Makoto Sunagawa is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (31 papers), Antibiotic Resistance in Bacteria (27 papers) and Synthesis of β-Lactam Compounds (20 papers). Makoto Sunagawa collaborates with scholars based in Japan and United States. Makoto Sunagawa's co-authors include Akira Sasaki, HARUKI MATSUMURA, MASATOMO FUKASAWA, Yutaka Ueda, Takao Ohta, Shiro Terashima, Yoshio Ito, Yoshihiro Sumita, Shô Itô and Naoto Kusunose and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Antimicrobial Agents and Chemotherapy and The Journal of Organic Chemistry.

In The Last Decade

Makoto Sunagawa

69 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Makoto Sunagawa Japan 18 414 309 280 223 133 70 952
Oludotun A. Phillips Kuwait 20 579 1.4× 235 0.8× 434 1.6× 179 0.8× 87 0.7× 75 1.2k
George Y. Lesher United States 15 606 1.5× 349 1.1× 562 2.0× 176 0.8× 111 0.8× 45 1.4k
Thomas Lampe Germany 15 422 1.0× 182 0.6× 477 1.7× 91 0.4× 74 0.6× 22 1.2k
Dennis D. Keith United States 25 435 1.1× 392 1.3× 525 1.9× 152 0.7× 52 0.4× 54 1.1k
D. T. W. CHU United States 15 214 0.5× 399 1.3× 404 1.4× 237 1.1× 127 1.0× 27 896
A. Kathrine Miller United States 11 368 0.9× 513 1.7× 414 1.5× 419 1.9× 224 1.7× 25 1.2k
Tsutomu Irikura Japan 15 332 0.8× 712 2.3× 753 2.7× 635 2.8× 156 1.2× 67 1.6k
Takashi Tsuruoka Japan 26 751 1.8× 416 1.3× 700 2.5× 49 0.2× 67 0.5× 74 1.8k
Jon G. Sundelof United States 12 249 0.6× 768 2.5× 260 0.9× 632 2.8× 343 2.6× 18 1.5k
Jos Hoogmartens Belgium 19 159 0.4× 315 1.0× 354 1.3× 71 0.3× 106 0.8× 64 1.2k

Countries citing papers authored by Makoto Sunagawa

Since Specialization
Citations

This map shows the geographic impact of Makoto Sunagawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Sunagawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Sunagawa more than expected).

Fields of papers citing papers by Makoto Sunagawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makoto Sunagawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Sunagawa. The network helps show where Makoto Sunagawa may publish in the future.

Co-authorship network of co-authors of Makoto Sunagawa

This figure shows the co-authorship network connecting the top 25 collaborators of Makoto Sunagawa. A scholar is included among the top collaborators of Makoto Sunagawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makoto Sunagawa. Makoto Sunagawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sunagawa, Makoto, et al.. (2009). An 11-Year-Old Boy with Familial Hypercholesterolemia Showing Multiple Xanthomas and Advanced Atherosclerosis, Who Responded to Lipid-Lowering Therapy Using Statin. Journal of Atherosclerosis and Thrombosis. 16(5). 698–701. 8 indexed citations
3.
Nomura, Takehiko, et al.. (2009). Morphological study on Mycobacterium bovis BCG Tokyo 172 cell wall skeleton (SMP-105). Journal of Microbiological Methods. 77(2). 139–144. 13 indexed citations
4.
Fujita, Yukiko, et al.. (2007). Molecular and supra-molecular structure related differences in toxicity and granulomatogenic activity of mycobacterial cord factor in mice. Microbial Pathogenesis. 43(1). 10–21. 27 indexed citations
6.
Fujita, Yukiko, et al.. (2007). Comprehensive analysis of mycolic acid subclass and molecular species composition of Mycobacterium bovis BCG Tokyo 172 cell wall skeleton (SMP-105). Journal of Microbiological Methods. 72(2). 149–156. 15 indexed citations
7.
Yoshida, Tomohide, et al.. (2006). Serum C-Reactive Protein and Its Relation to Cardiovascular Risk Factors and Adipocytokines in Japanese Children. The Journal of Clinical Endocrinology & Metabolism. 91(6). 2133–2137. 33 indexed citations
8.
Ueda, Yutaka, et al.. (2005). In Vitro and In Vivo Antibacterial Activities of SM-216601, a New Broad-Spectrum Parenteral Carbapenem. Antimicrobial Agents and Chemotherapy. 49(10). 4185–4196. 26 indexed citations
9.
Sunagawa, Makoto, et al.. (2005). Congenital atresia of the left main coronary artery: successful surgical treatment (myocardial revascularisation and mitral valve repair) in a 1-year-old boy. European Journal of Pediatrics. 164(7). 461–462. 7 indexed citations
10.
Sunagawa, Makoto, et al.. (2004). Low-Density Lipoprotein Particle Size and Its Regulatory Factors in School Children. The Journal of Clinical Endocrinology & Metabolism. 89(6). 2923–2927. 24 indexed citations
11.
Sasaki, Akira & Makoto Sunagawa. (1998). Recent advances in carbapenem chemistry (review). Chemistry of Heterocyclic Compounds. 34(11). 1249–1265. 3 indexed citations
12.
Sunagawa, Makoto & Akira Sasaki. (1996). Recent Advances in Carbapenem Chemistry.. Journal of Synthetic Organic Chemistry Japan. 54(9). 761–771. 5 indexed citations
14.
Sunagawa, Makoto, et al.. (1995). Structural analysis by NMR of antitumor drug-DNA complexes: 9-aminoanthracycline (SM-5887). Bioorganic & Medicinal Chemistry Letters. 5(23). 2923–2928. 9 indexed citations
15.
Takeuchi, Yutaka, et al.. (1993). Studies on the structures of meropenem(SM-7338) and it's primary metabolite.. The Journal of Antibiotics. 46(5). 827–832. 29 indexed citations
16.
Sasaki, Akira, et al.. (1992). Synthetic Studies of Carbapenem and Penem Antibiotics. II. Synthesis of 3-Acetyl-2-azetidinones by (2+2) Cycloaddition of Diketene and Schiff Bases.. Chemical and Pharmaceutical Bulletin. 40(5). 1094–1097. 5 indexed citations
17.
Sunagawa, Makoto, et al.. (1992). Synthesis and biological properties of 1.BETA.-methyl-carbapenems with N-methylpyrrolidinylthio group at C-2 position.. The Journal of Antibiotics. 45(6). 971–976. 9 indexed citations
18.
Sunagawa, Makoto, et al.. (1992). Synthetic Studies of Carbapenem and Penem Antibiotics. IV. Stereoselective Reduction of 3-Acetyl-2-azetidinone with Aminoalkoxyborane.. Chemical and Pharmaceutical Bulletin. 40(11). 3076–3078.
19.
Sunagawa, Makoto, Hiromi Satō, & Junki Katsube. (1980). Dibenzotetracyclic derivatives. III. Synthesis of 9-.GAMMA.-methylaminopropyl-9,10-dihydro-9,10-propanoanthracene.. Chemical and Pharmaceutical Bulletin. 28(5). 1644–1647. 3 indexed citations
20.
Kodama, Mitsuaki, Chizuko Kabuto, Makoto Sunagawa, & Shô Itô. (1977). Structure of inumakilactone D. Tetrahedron Letters. 18(33). 2909–2910. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026